Silencing splicing

Many sequences found within mammalian introns closely resemble the specific 5' and 3' splice site consensus signals that regulate exon splicing. It is unclear how the real splice sites are selected from these frequent pseudosites. In the September Molecular and Cellular Biology, Fairbrother and Chasin identified intronic splicing silencers using a genetic screen (Mol Cell Biol 2000, 20:6816-6825). They selected human genomic sequences that could disrupt splicing when inserted into the central ex

Written byJonathan Weitzman
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Many sequences found within mammalian introns closely resemble the specific 5' and 3' splice site consensus signals that regulate exon splicing. It is unclear how the real splice sites are selected from these frequent pseudosites. In the September Molecular and Cellular Biology, Fairbrother and Chasin identified intronic splicing silencers using a genetic screen (Mol Cell Biol 2000, 20:6816-6825). They selected human genomic sequences that could disrupt splicing when inserted into the central exon of a three-exon minigene. About a third of the randomly generated human genomic restriction fragments (approximately 100 base pairs long) could inhibit splicing. In contrast, inhibitory elements in bacterial genomic fragments were over ten times less frequent. The sequences of inhibitory fragments were enriched for G triplets and quartets, which have previously been implicated in intron definition. The authors suggest that mRNA splicing occurs against a background of repression that ensures the silencing of inappropriate splice sites.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies